Upon successful completion of this course, you will be able to:
- Discuss the endocannabinoid system
- Explain the pharmacology of cannabis
- Describe when the use of medical marijuana may be contraindicated
- List Ohio-approved delivery methods for medical cannabis
- Discuss cannabis' legal status under federal law, as it is legal in certain circumstances
- Identify what conditions qualify for the use of medical marijuana in Ohio State
- Recognize adverse effects of cannabis use
Developed by TMCIGlobal and approved by the Ohio State Medical Association, this online curriculum is designed to educate physicians who wish to apply for a Certificate to Recommend through the Ohio Medical Marijuana Control Program. Read More
Purchase grants one learner one year’s access to lessons and quizzes (access expires 365 days from the date of course activation).
NOTE: Bulk pricing is available! Call 844.490.2569 or email email@example.com.
OH Continuing Education Information: Ohio State Healthcare Provider Education: Medical Use of Marijuana
- Release date: August 2, 2018
- Expiration date: June 30, 2020
- Estimated time to complete activity: 2 hours
- Jointly provided by Postgraduate Institute for Medicine and Scitent.
- The basic function of the endocannabinoid system in various tissues, organs, and body systems.
- The physiologic effect of cannabis on body systems and the side effects of cannabis that patients may experience.
- The pharmacokinetics of cannabis absorption, distribution, metabolism and elimination in order to facilitate patient treatment.
- List common delivery methods for medical cannabis
- Identify considerations for each delivery method
- Identify what conditions qualify for medical marijuana use in Ohio State
- Understand how marijuana is used in the treatment of these conditions
- The differences in the absorption and metabolism rates with different methods of cannabis administration in patient treatment.
- Cannabis dependence, addiction, tolerance, and withdrawal.
Ethan Russo, MD: Dr. Russo is a neurologist and Director of Research and Development at ICCI.
Michelle Sexton, ND: Dr. Sexton serves as Founder and Chief Executive Officer of Phytalytics LLC. Dr. Sexton serves as Executive Medical Research Director at the Center for the Study of Cannabis and Social Policy in Seattle, WA.
Sunil K. Aggarwal, MD, PhD, FAAPMR: Dr. Aggarwal serves as Palliative Medicine and Rehabilitation Medicine Physician in Private Practice and MultiCare Health System in Washington State, a Clinical Instructor at the University of Washington School of Medicine, and an Afilliate Assistant Professor of Geography at UW.